Quality of Life among Younger Women with Breast Cancer. by Biswajit, D
QUALITY OF LIFE AMONG YOUNGER WOMEN WITH 
BREAST CANCER
This dissertation is submitted to 
The Tamilnadu Dr MGR Medical University, Chennai in Partial 
Fulfillment of the Regulations for D.M. (Medical Oncology) 
Degree Examination of February 2008
CANCER INSTITUTE (W.I.A)
Adyar Chennai – 600 020.
CERTIFICATE
This  is  to  certify  that  this  dissertation  on  “QUALITY  OF  LIFE  AMONG 
YOUNGER WOMEN WITH BREAST CANCER” is a bonafide work done by Dr. 
Biswajit .D, in the Department of Medical Oncology, College of Oncolgical Sciences, 
Adyar, Chennai, under my overall supervision and guidance, to my satisfaction
Dr. T.G. Sagar, M.D, D.M.
Professor & Head
Chennai Department of Medical Oncology
Date : College of Oncological Science 
Adyar, Chennai – 600 020.
ACKNOWLEDGEMENT
I would like to take this opportunity to express my deep sense of gratitude to my 
esteemed teacher and guide Dr. T.G.Sagar, M.D, D.M.; Professor and Head , Division 
of Medical Oncology, Cancer Institute (W.I.A), Adyar, Chennai for his valuable help, 
guidance and encouragement throughout the course of this work and my postgraduate 
career.
I  am thankful  to  Dr.  Vidhubala,  Phd, Clinical  Psychologist,  Cancer  institute 
Chennai for her constant support and advice during the study.
I  express  my  heartful  gratitude  to  Dr.  Ganapathy  Ramanan M.D.D.M.; for 
providing the initiative to take up this study.
I also thank Dr. Rejiv Rajendranath  M.D, D.M., Assistant Professor of medical 
oncology for his constructive criticism and support through out the study period.
I am extremely grateful to all my colleagues for their help and support at all times 
during the study.
I  thank my parents  and my sister  for  their  moral  support  and encouragement 
during the study.
Finally I express my deep gratitude to all my patients for their kind cooperation, 
without whom this study would never have been possible.
CONTENTS
CHAPTE
R NO.
TITLE
PAGE 
NO.
1. INTRODUCTION 1
2. AIMS 3
3. REVIEW OF LITERATURE 4
4. PATIENTS AND METHODS 29
5. RESULTS 33
6. DISCUSSION 52
7. CONCLUSION 60
8. REFERENCES 61
9. PERFORMA 68
INTRODUCTION
The diagnosis  of  breast  cancer  despite  improved overall  survival  continues  to 
generate fear and turmoil in the lives of women and their families. Prevalence studies of 
psychological  distress  indicate  that  one  of  every  three  newly  diagnosed  patients 
experiences significant difficulty in adjustment. [1] Further evidence suggests that the 
diagnosis of breast cancer generates more anxiety than any other cancer diagnosis. [2]
At the time of diagnosis patients experience uncertainty, confusion and distress. 
Psychological distress can be exacerbated by inadequate information, complex treatment 
decisions,  and  scheduling  difficulties  with  various  specialities.  As  treatment  begins, 
concerns  related  to  physical  functioning,  body  image,  mood,  sexuality,  family  and 
vocational  pursuits  quickly  emerge.  Surgical  options  which  include  lumpectomy, 
mastectomy and reconstruction present  unique issues as the patient contemplates the 
advantages and disadvantages of each procedure. Following surgery adjuvant therapy 
generates additional physiological assaults that further affect body image, sexuality and 
family life.
They  require  rehabilitative  assistance  beyond  the  physical  domain.  Major 
rehabilitation problem areas include physical, psychological, social, sexual, nutritional, 
financial and vocational ones.
For  younger  women  the  physical  and  psychosocial  morbidity  associated  with 
treatments may affect their ability to successfully function in social roles that typify this 
age group. Hence we would like to study the quality of life issues in this subset.
AIMS
1. To describe the quality of life among breast cancer women with age less than or 
equal to 35 years at the time of diagnosis.
2. To determine the contribution of socio demographic, medical and psychosocial 
factors on quality of life.
3. To  study  the  impact  of  breast  conservation  treatment  and  mastectomy  on the 
quality of life.
REVIEW OF LITERATURE
Young breast cancer patients have an aggressive behavior with poor outcome .The 
patients are in their reproductive age group and are concerned with fertility issues. The 
literature pertaining to quality of life in this subset is limited.
Incidence of breast cancer
In  India  the  incidence  of  breast  cancer  has  steadily  increased  over  the  year’s 
with100000 new cases being diagnosed every year. At a given time there are as many as 
1 million patients with breast cancer in India. The life time risk of developing breast 
cancer  is  1:30(incidence  rate  20/100000)  in  urban  India  and  1:65(Incidence  rate: 
8.6/100000) in rural India. [3]
Defining young breast cancer patient:
Of the three defining indicators , two of these- women having young children and 
women who have  not yet reached menopause are objective, the third being women of 
child bearing age which is subjective.[4]
The carcinomas arising in women aged 35-44 years are not significantly different 
from those occurring in women aged 50-67 years. The carcinomas arising in women 
aged  less  than  35  yrs  are  clearly  different.  This  emphasizes  the  importance  of  the 
subdivision of 50 years age group. [5]
Trends in Breast cancer in younger women in contrast to older women
Incidence
According to data from the Surveillance, Epidemiology and End Results program 
(SEER) and the National centre for health statistics, the probability of developing breast 
cancer were less than 1% between the ages 20 and 29 and 6.5% between ages of 30 and 
39. The absolute number of breast cancer nearly doubled in young women from 1970 
to1990 but the age adjusted breast cancer increased only slightly. In U.K., the incidence 
of breast cancer in the 20-24 year age group is 1.2 per 100000 and between 15-19 years 
of age the rate is 0.3 per 100000 women. [6]]
Clinical profile [7]
The breasts are physiologically more active resulting in cyclic nodularity making 
breast  self  examination  and  physical  examination  more  difficult.  Mammograms  are 
difficult to interpret owing to the density of the breast. A delay in diagnosis is more 
likely in young breast patients.
They  present  with  large  tumors  and  a  five  fold  increase  in  inflammatory 
carcinoma in women less than 30 years relative to those over 50 years.
The various risk factors which were higher when compared to older women were 
first birth at late age, low parity, oral contraceptive pills, positive family history of breast 
cancer and atypical ductal hyperplasia. [8]
The hereditary breast cancer constitutes 36 % to 85% of patients diagnosed with 
breast cancer under the age of 30. A study by Ashutosh et al revealed that the incidence 
of a positive family history was similar to the general population with breast carcinoma.
Pathology
The relative incidences of medullary carcinoma and ductal carcinoma in situ are 
increased. Lobular and tubular cancers are decreased. They presented with higher tumor 
grade, positive lymph nodes, extensive intraductal component, lymphovascular invasion, 
major mononuclear cell reaction, and hormonal receptor negativity. [7]
Although c-erbB-2 expression has been related to poorer differentiation, there was 
no difference in expression between the different age groups. [5]
A greater  percentage  of  tumors  with  S-  phase  fractions  were  correlated  with 
decreasing age. 80% of tumors from women of ages 30-35 had abnormal accumulation 
of  mutant  p53  protein. [9] Multivariate  analysis  confirmed  that  young  age  was  a 
significant independent predictor of adverse outcome.
Management
The issue of local control in young women has been the subject of conflicting 
reports in literature. Mathew et al suggested that local control rates in young women are 
more  a  function  of  histopathology,  biologic  features  than  the  surgical  procedure 
performed. [10]
The incidence of  chemotherapy induced ovarian failure is  related to the drugs 
administered,  total dose and age of the patient.  Alkylating agents are more likely to 
induce ovarian failure. Older premenopausal women experience ovarian failure more 
than their younger counterparts. CMF resulted in amenorrhea in 50% of women under 
the age of 40 years and 93% over the age of 40. The data on total dose indicate that 
permanent amenorrhea occurs after a mean total dose of 9.3 grams of cyclophosphamide 
in less than 40 yrs versus 5.2 grams in patients over the age of 40. [11]
The risk of osteoporosis and cardiovascular disease is increased in a milieu of 
estrogen deprivation.
Because  50  % of  the  patients  under  the  age  of  40  years  retain  their  ovarian 
function, pregnancy is an option. Limited scientific information is available. A small 
series  of  patients  with  breast  conserving  therapy  and  subsequent  pregnancy  were 
matched with women without pregnancy. No differences were noted for quality of life, 
local recurrences or survival. [7]
Survival patterns
Marie  Swanson et  al.,  in  their  study  found  that  women in  these  younger  age 
groups 20-29 and 30-39- constitute about 7% of white breast cancer patients and 14% of 
black breast cancer patients. They account for 9.7% and 17.2 % of deaths among white 
and black women respectively. [12]
There  are  various  possible  explanations  for  the  poor  survival  experience  of 
younger women with breast cancer.
1. High estrogen levels induce more rapid tumor growth rate.
2. Poor prognostic factors that reduce survival as discussed earlier.
3. Higher mortality from breast cancer in part due to the lack of competing causes of 
death.
4. Biology of the disease which differs significantly among the younger women in 
contrast to women in their 50s or older.[12]
Young women’s concerns and quality of life issues (4)
The diagnosis and treatment of breast cancer in a young woman is a major stress 
that is followed by significant psychological morbidity. There are a number of reasons 
why young women with breast cancer may experience increased psychosocial morbidity 
compared with older women. [4]
1. From  a  developmental  perspective,  they  experience  the  stress  of  cancer 
concurrent to the multiple stressors associated with early stage of the family 
life cycle. 
2. Global QOL assessed by Ladder of life suggests that problems associated with 
breast cancer continue to persist several years after diagnosis. Kroenke et al 
found that  women less  than  40 yrs  of  age  experienced  greater  declines  in 
physical roles, bodily pains, social functioning, and mental health compared 
with women without breast cancer. [13] 
3. They may experience more disruption to self image and sexuality
4. They may have concerns about career, feeling unable to change jobs or fearing 
loss of a job.
5. They also experience premature menopause, resulting in a range of distressing 
physiological and psychological symptoms like vaginal dryness, hot flushes, 
dyspaurenia, mood swings and short term memory loss. [4]
6. Fears about not surviving to see their children grow to adulthood, infertility 
and cancer recurrences. The meaning of having children is an important aspect 
of quality of life not only in terms of the experience of pregnancy, child birth 
and mothering.  The  experience  of  breast  cancer  in  young women includes 
anxiety, depression, fear and anger. The fear is more related to concerns as not 
living to see their children grow up rather than the anxiety of relapse. [4]
Impact of Quality of life on specific treatment. [14]
Mastectomy  :  The loss of self esteem associated with mastectomy causes anger, anxiety, 
fear and sadness. The durations of these symptoms may be prolonged
Lumpectomy: Breast conservation provides an alternative to mastectomy that lessens 
the  effect  on  body  image  and  self  esteem.  However  some  women  may  opt  for 
mastectomy for the fear of recurrence. [15]
Reconstruction  :  Immediate or delayed reconstruction offers an opportunity to restore 
positive  body  image  and  to  increase  self  esteem.  An  intact  body  enhances  sexual 
functioning and satisfaction. [16]
Impact of breast – conserving treatment and mastectomy on the quality of life
In the treatment of early stage breast cancer, the issue of extensiveness of surgery 
has long been central. Rational decision making should be based on theory and empirical 
data with respect to three end points: [17]
1. Likelihood of local tumor control and survival.
2. The  burden of  the  treatment  experienced  by  the  patients  and  its  effect  on 
quality of life.
3. Costs of treatment.
Quality of life.
Meyerowitz et al    had suggested a model for impact of breast cancer and its 
treatments  on  the  patient.  The  main  areas  in  this  model  include  psychological 
discomfort, changes in life patterns, and fears and concerns. [18]
Psychological Discomfort
The  three  most  commonly  observed  symptoms  of  psychological  distress  are 
depression, anxiety and anger.  In 9 out of the 16 studies there was no difference in 
psychological distress between the different treatment modalities. 4 studies reported a 
difference  in  favor  of  breast-  conserving  group:  general  adjustment,  pessimism, 
emotional  adjustment,  depression,  emotional  reactions.  Two  studies  reported  a 
difference  in  favor  of  the  mastectomy  group:  depression  anger,  confusion,  overall 
distress and psychological distress. [17]
With respect to psychological distress there is a current lack of solid proof of a 
more favorable psychological adjustment after breast conserving treatment. Conserving 
the  breast  does  not  alter  the  adjustment  problems.  They  need  as  much  counseling 
support as patients who undergo mastectomy. [19]
Changes in life patterns 
It  is  measured  in  three  areas:  Physical  functioning/  daily  activities,  sexual 
functioning and social adjustments. In seven of the twelve studies, no difference was 
found between the two treatment arms.  In one study lymphedema was less and arm 
function was better after conservative treatment but in another the arm motion was better 
after  mastectomy.  [17]  Levy  et  al  reported  less  physical  disability  and  less  loss  of 
appetite after mastectomy. [20]
Physical function and activity level are similar according to most investigations. 
There was no difference between treatment groups in the long run.
Sexual functioning was investigated in 11 studies. No difference was found in 7 
studies. The differences found in the other studies were all in favor of breast conserving 
group.  More  dysfunction  ,  later  resumption  of  sexual  activities,  changes  in  breast 
stimulation,  talking  less  openly  about  sexuality,  and  less  satisfaction  with  sexual 
experiences were observed after mastectomy.[17]
Thus with regard to sexual functioning, it must be concluded that patients who 
undergo a mastectomy have an increased chance of the problems in this respect.
Social  adjustment  was  investigated  in  11  studies.  In  six  of  these  studies,  no 
differences  were  found  between  the  treatment  groups.  In  two  studies,  the  breast 
conserving  treatment  turned  out  to  lead  to  better  social  support  from friends,  more 
marital  affection  and  openness  about  feelings.  However  three  other  studies  reported 
more conflicts, difficulties in planning, less cohesion, and social support in this group. 
[17]
The effect on the marital and social relations of patients remains unclear. [17]
Fears and concerns 
12 of the 18 studies investigated aspects of body image after surgery. Of these, 
only 2 studies found no differences between treatments.  In the 12 studies that found 
differences,  a  more positive outcome with respect  to body image was found for  the 
groups with breast – conserving treatment. These patients felt more attractive and less 
ashamed, anxious, embarrassed, or concerned about their bodies.
The fear of recurrences and death was investigated in 8 studies. In six of them, no 
differences were found between the treatment options. Two studies reported more fear 
of recurrence after mastectomy than after breast conserving treatment. [17]
Financial aspect
The length and costs of breast conserving treatment with the subsequent follow up 
schedule are higher. [17]
The impact of different surgical treatment modalities in the case of early breast 
cancer on quality of life shows few differences. 
Adjuvant Chemotherapy
Alopecia,  fatigue,  hemorrhagic  cystitis,  myelosupression,  nausea  and  vomiting 
consistently affect the psychological well being; exacerbate the assaults on body image, 
sexual satisfaction and overall quality of life. [21, 22, 23]
Radiation therapy
The  most  frequently  cited  side  effects  are  fatigue,  which  inhibits  day  to  day 
functioning and thereby decreasing the quality of life. Patient also possesses significant 
concerns related to pain and the duration of treatment. [24, 25]
Psychosocial vulnerability
For breast cancer patient’s survivorship begins on the day of diagnosis as women 
begin to redefine all aspects of their lives. Four primary points exist in the psychosocial 
care of cancer patients. [26]
1. Patient experience an “existential plight” during the first 3 months after their 
diagnosis.[27]
2. If  a  remission  occurs,  patients  begin  to  live  with  cancer.  They incorporate 
disruptions of daily life into their routines.
3. The  fear  of  recurrence  complicates  the  psychosocial  course.  Patients  gain 
critical information and knowledge concerning their disease and treatments. 
They form supportive relationships with health care teams and other patients.
4. When  the  treatment  fails,  terminal  illness  and  the  potential  threat  of 
abandonment confronts.
Since  the  patients  vary  significantly  in  their  ability  to  adapt  to  their  cancer 
diagnosis and treatment, there are defined variables which promote adaptation.
Table 1. Variables associated with psychosocial adaptation. [28]
----------------------------------------------------------------------------------------
Social support
Marital status
Living arrangements
Number of family members and relatives in vicinity
History
Substance abuse
Depression
Mental health
Major illness
Current concerns
Health 
Religion
Work- finance
Family
Friends
Self appraisal
Others
Education
Employment
Physical symptoms
Sexuality and body image. [29]
A diagnosis of breast cancer in younger women has the greater potential impact of 
the cancer therapy on her reproductive life.
1. Mastectomy versus breast conservation  A number of studies have compared quality 
of life in women who had modified radical mastectomies or breast conserving surgery. 
Psychosocial adjustment, whether measured in terms of major psychiatric disorders or 
general levels of emotional distress, does not differ between treatment groups. Marital 
satisfaction or divorce rates also are quite similar in both the groups. Questions about 
body image demonstrate that women with less extensive surgery feel more attractive and 
sexually desirable [30,31].Pozo and colleagues noted that younger women were the most 
distressed patients in both the mastectomy and breast conserving groups when compared 
to older women.[29]
2. Breast reconstruction.
The sexual function and body image are more positive after breast reconstruction. The 
impact of breast reconstruction on sexual frequency and satisfaction is less clear. [29]
3. Systemic therapy and sexuality.
Chemotherapy  was  related  to  greater  sexual  problems  after  surgery  and  continued 
beyond the first year of treatment. Ganz et al found that sexual functioning was most 
impaired for women no longer menstruating after chemotherapy. [32]
The  clinical  symptoms  of  premature  menopause  include  sudden  onset  of  hot 
flashes, vaginal dryness, and atrophy, Dyspareunia. Post menopausal vaginal atrophy is 
associated with recurrent urinary tract infections or vaginal monilial infections. [33] The 
alopecia, weight gain and pallor often associated with chemotherapy can temporarily 
make women feel unattractive. One other hormonal change that may occur is a decrease 
in circulating androgens. About 50 % of the circulating androgens are of ovarian origin 
while the rest are produced by the adrenals .It may interfere with a woman’s desire and 
arousability.[34]
The  onset  of  vaginal  dryness  from abrupt  menopause  is  the  important  factor 
affecting  sexual  functioning.  The  long  term  impact  of  chemotherapy  on  sexual 
functioning is thus related to its impact on ovarian functioning. 
Younger women whose ovarian function returns after chemotherapy and women 
already postmenopausal may show only short term effects. Those women whose ovarian 
function is severely affected may show long term effects.[32,35]
The prevalence of hot flashes, difficulty with bladder control, vaginal dryness and 
stiffness and soreness were all higher in community based cohorts of women such as 
SWAN and the Melbourne Women‘s Midlife Health project.[36]
Fornander  and  colleagues  suggested  that  Tamoxifen  decreases  sex  hormone- 
binding globulins with net increase in the bioavailability of androgens. It also prevents 
vaginal atrophy. [37]
Understanding specific aspects of sexual problems that affect younger women and 
extend over  time is  relevant  for  oncologists.  Vaginal  rings,  a  form of  estrogen that 
dispenses low doses of estrogen with little systemic absorption and lubricants may prove 
beneficial. Although sexual functioning is an important quality of life issue for women, 
it may be difficult for patients to initiate discussion and the clinicians should routinely 
raise  the  topic.  Interventions  to  help  women  feel  more  sexually  attractive  may  be 
beneficial, especially among women for whom these feelings were altered as a result of 
treatment or surgery. [32]
Spirituality
One  salient  aspect  of  the  distress  of  life  threatening  or  terminal  illness  is 
spirituality. Smith and colleagues found that a higher level of spirituality is associated 
with an increase in the patient’s ability to normalize death. In the study of 116 adult 
medical oncology outpatients, a significant negative relationship was found between the 
interaction  of  spiritual  awareness  with  the  patient’s  personal  death  perspective  and 
psychosocial distress. [38]
Effects on Interpersonal and Family Relations. [39]
When breast  cancer  occurs  in  young  women,  the  demands  on  family  life  are 
heightened as family members cope simultaneously with day to day care of the children, 
careers, with the added worries of a life threatening diagnosis, surgery, and the toxic 
effects of chemotherapy.
1. Emotional impact
Younger women experience more emotional  distress.  They sought professional 
help more often and perceived mastectomy as having more negative influence on their 
sexual relationships than older women. They had significantly poorer mental health and 
a lower sense of well being
2. Emotional impact on spouses
Husbands of breast cancer patients have reported psychosomatic problems such as 
eating disorders and sleep disturbances, distress levels comparable to the levels reported 
by their wives, and feelings of heightened anxiety and depression, starting at the time of 
diagnosis and continuing through the first year of surgery.
3. Impact of breast cancer on children
The limited research in this area indicates that children like their parents, are not 
immune to the stressful effects of the illness. The adjustment levels of the children were 
affected by the marital adjustments of the parents and by the quality of the parent- child 
relationship
4. Impact of breast cancer on Marital Relationship.
Licthman et al studied the marital adjustment of breast cancer patients and found 
that the quality of relationship stayed the same or improved after the mastectomy. Only 
7% of the couples divorced .Younger couples reported higher marital satisfaction than 
the older  couples.  Only one fourth to one third of couples experience difficulties  in 
sexual problems. Many women with advanced breast cancer were able to discuss their 
illness with their family members [40].
Cognitive –Behavioral Interventions.
Patients frequently manifest a variety of symptoms as direct effects of cancer and 
its  treatment.  Most  commonly  identified  symptoms  include  acute  and  chronic  pain, 
anxiety,  insomnia,  hypochondrias  is,  anticipatory nausea  and vomiting.  A variety  of 
cognitive and behavioral interventions can systematically be administered. [14]
Survivorship
A number of studies indicate that while cancer survival may be achieved, it is still 
a disease that can substantially affect several physical and psychological aspects of a 
survivor’s life. Hyper vigilance and hypochondriasis are common reactions. [41] They 
experience challenges in four critical life domains. 1. Physical health, 2Psychological 
and social well being, 3.Maintaining adequate health insurance and 4. Employment. [42]
Physical health challenges include fear of recurrence, the possibility of second 
malignancy and other late effects of aggressive treatment. Many survivors actively meet 
these  challenges  through  preventive  regimes  of  diet,  exercise,  stress  reduction  and 
smoking cessation.  In  general  most  survivors  report  mild to  moderate  psychological 
distress. Cancer survivors often may be threatened with policy cancellations or reduction 
in coverage. [14]
Employment  issues  include  failure  to  be  promoted,  negative  attitude  toward 
cancer and undue criticism from supervisors or co workers. 
One of the most important variables consistently related to QOL was the number 
of days of work or usual activity missed in the 3 months after diagnosis. Those who 
reported missing all 3 months had lower quality of life on all domains. This measure is 
possibly associated with depression at the time of diagnosis. [14]
Qualities of life in long term, disease free survivors of breast cancer.
Deborah et al studied the quality of life of 5-10 year breast cancer survivors and 
found that the presence of symptoms at the time of survey and use of chemotherapy after 
diagnosis to be the strongest correlates of QOL. The Stage at diagnosis, age at survey, 
recurrence since diagnosis, and number of years since diagnosis did not highly correlate 
with QOL. [43]
Women who did not receive chemotherapy or hormonal therapy had higher QOL 
than women who received either type of therapy. Long-term consequences of adjuvant 
therapy may be particularly pronounced in terms of sexual issues. [43]
The findings from a large longitudinal study of QOL among long-term survivors 
across a broader age distribution, suggest that the effects of adjuvant therapy persist 
many years after the completion of chemotherapy. [44]
The  presence  of  inadequately  managed  breast  cancer  related  pain,  and  other 
cancer-related symptoms, many years after diagnosis may have a significant impact on 
the day-to-day well-being of younger survivors. [43]
A study among 8 year survivors of a consecutive series of women with breast 
cancer showed that the quality of life of survivors who remained free of disease during 
the entire follow up period was similar to that among women who had never confronted 
cancer. Two exceptions where survivors experienced poorer quality of life were more 
frequent arm problems and less satisfaction with sexual life. [45]
Conclusion
Patient  and  families  have  very  personal  perceptions  of  breast  cancer  and 
treatments  that  are  influenced and developed over  time as a  result  of  many factors. 
Information and education must be consistently available as patients and families move 
across the disease continuum from diagnosis to treatment to recovery. Comprehensive 
Psychosocial  assessment  should  also  include  intimacy,  sexuality  and  spirituality. 
Undetected  and  untreated  psychological  distress  can  jeopardize  treatment  outcome, 
stimulate dissatisfaction with care, and increase overall health care costs.
Menopausal symptoms and problems with relationship, sexual functioning, and 
body image might explain why younger women have greater psychological morbidity. 
Preparing younger women for the impact of breast cancer and helping women deal with 
problems may improve their quality of life. Younger breast cancer survivors may be in 
need of interventions that specifically target these issues. Clinicians should monitor how 
women respond to their  diagnosis  in  terms of  stopping work or  their  usual  activity. 
Women who stop working or their usual activity are at significantly greater risk for 
impaired quality of life in all domains and should be targeted for intervention.
PATIENTS AND METHODS
Younger  Women  diagnosed  as  breast  cancer  at  Cancer  Institute  (WIA),  who 
underwent  the  Institute’s  protocol  treatment  from 1994-2005  were  included  for  the 
study.
Inclusion criteria
1. Age less than or equal to 35 years.
2. Patients with TNM stage I, II and III.
3. Patients who have completed 18 months of follow up.
Exclusion criteria
1. Patients with metastatic disease
2. Patients with histopathological diagnosis of Sarcomas and Lymphomas
Methods
Sample
The  medical  records  of  100  patients  who  met  the  inclusion  criteria  from 
1994-2005 were reviewed and included in the study. Women were then contacted on 
phone  or  letter  to  review  at  the  breast  cancer  clinic  where  the  quality  of  life 
questionnaire was administered after taking informed consent. Out of the patients who 
had been contacted 51% of them responded.
Treatment 
Depending on the stage of the disease, patients had received neo-adjuvant chemo 
radiotherapy and hormonal therapy as per the institute protocol. 
Questionnaire
Sociodemographic  variables  included  age  at  diagnosis,  marital  status,  level  of 
education  and  employment  status.  Medical  variables  included  cancer  stage,  type  of 
surgery,  hormonal  status,  menopausal  status,  ovarian  function  and  child  birth  after 
diagnosis.
Quality of life 
The quality of life issues were studied using the EORTC module QLQ –C30 and 
the BR 23 Questionnaire. The questionnaire has been validated on Indian patients. [46]
EORTC QLQ C 30 and BR 23
The EORTC module QLQ-C30 is a 30 item questionnaire composed of 5 multi 
item functional subscales : Physical health , role function, emotional function, cognitive 
function and social functioning; 3 multi item symptom scales measuring fatigue, pain 
and emesis; a global health subscale and 6 items to assess financial impact and general 
symptoms .
The BR-23 module evaluates treatment – related symptoms of breast cancer. It 
incorporates 3 functional scales (body image, future perspectives and sexuality) and 4 
symptom scales (arm symptoms, breast symptoms, hair loss and side effects of systemic 
therapy).  In  addition  to  this,  a  few  other  issues  related  to  sexual  dysfunction  and 
menopausal symptom were also assessed 
The questionnaires were available in 4 languages namely English, Tamil, Telugu 
and  Malayalam  which  were  administered  according  to  the  patient’s  vernacular 
languages. Patients completed their questionnaire on their own; however some of them 
required assistance. 
Statistical Analysis.
Scoring of  the QLQ – C30 and BR-23 was done according to  the procedures 
described in the EORTC manual.
Descriptive and inferential statistics were used in order to analyze the data using 
SPSS version 13.
RESULTS
Table 1 Age at Diagnosis
Age(years) N=51(%)
21-25 7 (13.7)
26-30 27 (52.9)
31-35 17 (33.4)
Table 2 Educational status
N=51
Primary 27 (52.9)
Secondary 17 (33.33)
Graduate 6 (11.8)
Postgraduate 1 (2)
Table 3 Occupation before and after diagnosis of cancer
  Occupation                                          After
Before Housewife labourers professional
Housewife 37 2 0
Labourers 1 10 0
Professional 1 0 0
Table 4 Marital status before and after diagnosis of cancer
Marital status                                           After
Before Married Divorced widow single
Married 42 2 2 0
Single 4 0 0 1
Table 5 Stage and Treatment
Characteristics No of patients
Stage
I 2   (3.9)
II 31 (60.8)
III 18  (35.3)
Type of surgery
MRM 33 (64.7)
BCS 18 (35.3)
Chemotherapy 51 (100)
Type of chemotherapy
CMF 32 (62.7)
FAC 16 (31.4)
FEC 3 (5.9)
Radiotherapy 51 (100)
*MRM- modified radical mastectomy, BCS-Breast conservation surgery,
CMF-Cyclophosphamide, Methotrexate, 5-Fluorouracil
FAC-5-Fluorouracil, Adriamycin, Cyclophosphamide.
FEC-5-Fluorouracil, Epirubicin, Cyclophosphamide.
Table 6 Hormonal manipulation
Characteristics No of patients %
Hormone therapy 42 82.4
BSO 22 43.1
Radiocastration 4 7.8
Chemo induced amenorrhea 9 17.6
Table 7 Sexual and menopausal symptoms
Symptoms N=51 (%)
Hot flashes 16 (31.4)
Vaginal dryness 7 (13.7)
Vaginal discharge 11 (21.6)
Dysparuenia 11 (21.6)
Normal menstrual cycles 22 (43.1)
Table 8 Sexual function and Hormonal Therapy
Item scale Hormonal N Mean SD sig
therapy scores
Sexual 
functioning
yes 29 67.57 35.48
no 22 33.44 33.31
0.01
Sexual 
enjoyment
yes 29 64.28 37.16
no 22 29.55 35.16
0.013
Table 9 Quality of life (Functional Scales)
Item scale Mean scores SD
Physical functioning 86.39 17.56
Role functioning 87.01 22.67
Emotional Functioning 82.11 23.20
Cognitive functioning 89.25 19.81
Social  functioning 87.7 24.6
Body image 80.44 28.63
Sexual functioning 61.54 37.18
Sexual enjoyment 58.15 38.84
Future perspective 72.62 33.81
Table 10 Quality of life (Symptom Scales)
Item scale Mean scores SD
Global health status 77.93 20.74
Fatigue 18.10 22.1
Pain 19.60 26.64
Insomnia 8.49 25.68
Appetite loss 5.88 17.30
Breast symptoms 8.98 14.51
Arm symptoms 15.52 20.35
Systemic side effects 13.04 11.93
Financial difficulties 40.5 39.67
Table 11 Impact of MRM and BCS on Quality of life. (Functional scale)
Item scale Therapy N Mean 
scores
SD Sig
Physical functioning MRM 33 87.81 17.32
BCS 18 83.77 18.18
0.43
Role functioning MRM 33 89 21.44
BCS 18 83.38 24.98
0.40
Emotional 
Functioning
MRM 33 83.68 22.86
BCS 18 79.25 24.21
0.52
Cognitive functioning MRM 33 89.51 17
BCS 18 88.77 24.69
0.90
Social  functioning MRM 33 87.96 26.02
BCS 18 87.22 22.44
0.91
Body image MRM 33 82.38 26.2
BCS 18 76.88 33.03
0.51
Sexual functioning MRM 33 70.33 34.51
BCS 18 45.44 37.41
0.02
Sexual enjoyment MRM 33 69.72 35.75
BCS 18 36.94 36.00
0.003
Future perspective MRM 33 71.81 31.33
BCS 18 74.11 38.75
0.82
Table 12 Impact of MRM and BCS on Quality of life (symptom scale)
Item scale Therapy N Mean scores SD sig
Global MRM 33 82.31 18.01
BCS 18 69.90 23.42
0.04
fatigue MRM 33 18.07 21.25
BCS 18 18.16 24.42
0.98
Pain MRM 33 17.65 25.02
BCS 18 23.14 29.82
0.49
Insomnia MRM 33 8.06 25.02
BCS 18 9.27 27.58
0.87
Appetite loss MRM 33 8.06 17.62
BCS 18 5.55 17.18
0.92
Breast sym MRM 33 9.84 16.19
BCS 18 7.40 11.02
0.571
Arm sym MRM 33 10.91 17.73
BCS 18 23.98 22.58
0.027
Systemic side 
effects
MRM 33 12.28 10.59
BCS 18 14.49 14.3
0.54
Financial
difficulties
MRM 33 38.36 36.51
BCS 18 44.44 45.26
0.60
Table 13 Impact of Ovarian function on Quality of life
Item scale Therapy N Mean scores SD sig
Global
functioning
Ablated 29 78.44 21.07
Preserved 22 77.26 20.26
0.84
Physical
functioning
Ablated 29 85.96 19.04
Preserved 22 86.95 15.81
0.84
Emotional 
Functioning
Ablated 29 78.77 25.55
Preserved 22 86.51 19.37
0.24
Cognitive 
functioning
Ablated 29 92.31 13.59
Preserved 22 85.22 25.65
0.20
Social  functioning Ablated 29 85.75 27.32
Preserved 22 90.27 20.89
0.52
Body image Ablated 29 77.60 30.42
Preserved 22 84.18 26.32
0.42
Arm
symptoms
Preserved 29 12.1 19.26
Ablated 22 19.9 21.33
0.174
Sexual functioning Ablated 29 70.24 35.75
Preserved 22 50.09 36.88
0.05
Sexual enjoyment Ablated 29 71.27 35.38
Preserved 22 40.86 37
0.004
Future perspective Ablated 29 70.17 36.04
Preserved 22 75.86 31.15
0.551
Table 14 Impact of survival duration on quality of life
Item scale Therapy N Mean scores SD Sig
Global
functioning
<=5yrs 33 79.53 20.53
>6yrs 18 74.99 21.39
0.46
Physical
functioning
<=5yrs 33 87.42 17.18
>6yrs 18 84.5 18.57
0.57
Emotional 
Functioning
<=5yrs 33 84.92 20.10
>6yrs 18 77.88 28.16
0.34
Cognitive 
functioning
<=5yrs 33 88.66 22.17
>6yrs 18 90.33 15.07
0.77
Social 
functioning
<=5yrs 33 90 19.86
>6yrs 18 83.5 31.81
0.37
Body 
image
<=5yrs 33 82.14 26.91
>6yrs 18 77.32 32.13
0.57
Sexual 
functioning
<=5yrs 33 60.66 37.68
>6yrs 18 63.16 37.27
0.82
Sexual 
enjoyment
<=5yrs 33 55.51 37.96
>6yrs 18 63 41.08
0.51
Future 
perspective
<=5yrs 33 72.78 32.79
>6yrs 18 72.33 36.58
0.96
Arm 
symptoms
<=5yrs 33 7.06 9.79
>6yrs 18 12.49 20.46
0.20
Breast 
symptoms
<=5yrs 33 15.34 20.0
>6yrs 18 15.87 21.58
0.93
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Figure 4. Fear and partner response to MRM and BCS
A  total  of  51  patients  who  attended  the  breast  clinic  and  completed  the 
questionnaire were taken up for the study.
The mean age at  diagnosis  was 30 years  (21-35yrs)  with 51% of the patients 
between the age group of 29 to 32 years. (Table1)
The mean age at the time of quality of life analysis was 35.1 years (23-47).
Demographic profile
Education status   (  Table 2)
27(52.9%)  patients  had  completed  primary  education.  Only  1patient  was  a 
postgraduate. None of the patients in the study group was illiterate.
Occupation (Table3)
37(74.5%) patients were housewives at the time of diagnosis. 2 patients who were 
housewives  at  diagnosis  took up a  job as  a  labourer  after  the diagnosis  of  cancer.1 
labourer and the other a professional left their jobs and became house wives. 
Marital status (Table4)
Of the  48  patients  who were  married,  2  got  divorced  and 2  of  them became 
widows during the course of the treatment. Of the 5 who were single at diagnosis, 4 got 
married and 1 continued to be single.
Family history of cancer was present in 6 patients (11.8%).
Stage and treatment (Table 5)
31 (60.8%) patients  were  in  stage 2.Only  2 patients  presented in  stage 1.  All 
patients  underwent  surgery  with  35%  of  the  patients  receiving  breast  conservation 
surgery.  Based  on  the  protocol  treatment  at  our  institute  all  the  patients  received 
adjuvant  chemotherapy  and  radiotherapy.  62.7%  of  the  patients  received  CMF 
chemotherapy as per the institute protocol
Hormonal manipulation (Table 6)
Bilateral  salpingo  oopherectomy  was  done  in  43.1  %  of  the  patients,  while 
radiocastration in 7.8% of the patients. 9 patients (17.6%) had chemotherapy induced 
amenorrhea of which 3 had permanent ovarian failure.
Receptor Status (Figure 1)
49% of the patients were receptor negative while in 29.4% of the patients the 
receptor  status  was  unknown.  Hormonal  therapy  was  administered  to  82.4% of  the 
patients.
Menopausal status and child birth
22 (43.1%) patients had intact menstrual function of which only 2 patients had 
irregular cycle. Premature menopause was seen in 29 patients. Of the 9 patients with 
chemotherapy induced amenorrhea, 3 patients had permanent ovarian dysfunction. 
3 patients had successful pregnancy after completion of therapy
The mean duration of follow up was 5.33 years (2yrs-17yrs).
Sexual and menopausal symptoms (Table 7)
Premature  menopausal  symptom  was  experienced  in  the  form  of  hot  flashes 
in31.4 % of the patients. The common sexual symptoms were vaginal dryness (13.7%), 
vaginal discharge (21.6%) and Dysparuenia (21.6%). The sexual symptoms appeared to 
be  higher  in  the  ovary  ablated  group when compared to  the  ovary  preserved group 
(figure2). 
Patients who had received hormonal therapy had a higher sexual function score 
and sexual enjoyment score than who didnot which was statistically significant.(Table8/ 
figure 3)
Quality of Life
The EORTC QLQ C30 and BR23 questionnaire was used for the assessment of 
the quality of life.
A high score for a functional scale represents a high /healthy level of functioning, 
a high score for the global health status/ QOL represents a high QOL, but a high score 
for  a  symptom  scale/item  represents  a  high/  healthy  level  of  symptomatology  or 
problems.
The mean global health status score was 77.93. The functional scores of physical, 
role, emotional, cognitive, social and body image were high ranging from 80 to89.The 
functional scores of  sexual function, sexual enjoyment and future perspective were low 
in the range of 58 to72. (Table 9)
The symptoms scales of fatigue, pain, insomnia, loss of appetite, breast and arm 
symptoms and systemic side effects were  low in the range of 5 to 20.Only the financial 
score of the symptom scale  was high with a score of 40.5. (Table10)
Impact of MRM and BCS on quality of life
Functional scale (Table 11)
The  functional  scores  of  physical,  role,  emotional,  cognitive  and  social  were 
slightly higher or similar in both the mastectomy and breast conserving group and not 
statistically significant. The sexual functioning and sexual enjoyment were significantly 
better in the mastectomy group when compared to the breast conservation group. The 
scores for body image was also higher in the mastectomy group but was not statistically 
significant. Only the future perspective was higher in the BCS group 
Symptom scale (Table12)
The global health status was significantly better in the mastectomy group than the 
BCS  group.  The  arm  symptoms  were  also  statistically  significant  in  the  breast 
conserving group. The financial problems were also more in the BCS group. The other 
symptom scales  like fatigue and insomnia was similar  in both the groups.  Pain was 
found to be slightly higher for the BCS group. 
The fear of recurrence was higher in the MRM group when compared to BCS 
group. The fear of functional disability was higher in the BCS group. 
With respect to their partners, the percentages of patients with BCS had higher 
partner neglect (28%) and also were overprotected (28%) more than the MRM group. 
(Figure 4.)
Impact of Ovarian function on quality of life. (Table 13)
The sexual functioning and enjoyment were better in the ovary ablated group than 
the ovary preserved group and was statistically significant. The emotional, social, body 
image and future perspective appears to be better in the ovary preserved group though 
statistically not significant.
The overall global health status appears to be similar in both the groups.
Survival duration and Quality of life (Table 14)
The emotional and body image scores were slightly less in those with more than 6 
years of follow up when compared to those with less than or equal to 5 years of follow 
up. The arm symptoms were also slightly higher in this group. The global quality of life 
and other functional and symptom scales were similar in both the groups. 
DISCUSSION
The incidence of breast cancer in the age group 20-29yrs is less than 1% and 6.5% 
in the age groups 30-39yrs. The patients are in their reproductive age group and are 
concerned with fertility issues. Moreover there is a paucity of Indian data with respect to 
quality of life in this subgroup.
Impact of breast cancer on the demographic profile.
2 housewives had to take up a job as a result of financial difficulties following the 
diagnosis of cancer.2 patients had to leave their jobs and  they attributed it to partner’s 
overprotection.  With respect  to  marital  status,  2  patients  got  divorced following the 
diagnosis of cancer. 4 of the 5 patients who were single got married after diagnosis. 
The effect of breast cancer on the occupation and marital status did show some 
effect but the magnitude of the effect was not much as most of us would expect.
Kiebert et al have reported that marital and social relations appear to be unclear 
with  6  of  the  11  studies  reporting  no  difference  and  the  other  studies  reporting 
differences that are inconsistent. [17]
Impact of treatment on quality of life
The study population constituted of young breast cancer patients who are long 
term survivors .The mean duration of follow up was 5.33 years. Our study concentrates 
on the quality of life issues in this subset.
The global health status and the functional scores of physical, role emotional , 
social  cognitive and body image was comparable but the sexual functioning was lower 
compared to a study conducted in Indian women with breast cancer by Parmar et al. The 
arm and breast symptoms appear to be lower in our study when compared to the study 
by Parmar et al. [46]
1. Breast conservation and Mastectomy  
It was surprising to note that the functional scores were better in the mastectomy 
group with sexual functioning and sexual enjoyment achieving statistical significance.
A  review  by  Kiebert  et  al  reported  4  studies  with  relation  to  psychological 
dimension  in  favor  of  the  BCS  group  while  there  were  2  studies  in  favour  of 
mastectomy. [17]
With respect to sexual function, of the 11 studies there was no difference between 
the  groups  in  7  studies  while  4  other  studies  favoured  the  BCS  group.  But  with 
increasing time this difference became less obvious. Our study again was in patients 
with long term disease free survivors.
The global health status was higher in the mastectomy group. The arm symptoms 
and pain which was higher in the BCS group could be the reason for the lower quality of 
life in this group. 
Breast  conservation surgery did not  improve the body image score.  Of the 18 
studies reviewed, 12 studies were in favour of breast conservation while the rest of the 
studies showed no difference.
The fear  of  recurrence appeared to  be higher  in  the mastectomy group in  our 
study. The reason could be that patients felt that mastectomy was done for advanced 
disease and hence the higher chance of relapse. This was investigated in 8 studies. In 6 
of the studies no differences were found between the treatment options. Two studies 
favored the mastectomy group. [14, 47] 
The financial constraints also appeared to be higher for the BCS group but did not 
achieve statistical significance. This could be attributed to length and costs of breast 
conserving treatment with the subsequent follow up and screening mammogram being 
higher in this group.
The  impact  of  quality  of  life  on  the  two  treatment  groups  namely  the  breast 
conservation and mastectomy  are gross categories that fail to distinguish the variety of 
procedures and the adjuvant treatment like chemotherapy, radiotherapy and hormonal 
therapy. 
There are several confounding factors
1. The reason for the overall quality of life being poorer in the BCS group is that the 
arm symptoms and the pain are not dependent on whether the breast is conserved 
or  not.  The  arm  symptom  is  dependent  on  the  complication  of  the  axillary 
dissection and radiotherapy to the axilla resulting in lymphedema. The pain may 
be related to the injury to nerves.
2. Stephanie in her  study on sexual  problems after surgery found that  the sexual 
problems in younger women were not  related to socio demographic factors or 
type of breast cancer surgery.[32] The reason for sexual functioning to be better in 
the mastectomy group could be dependent on the hormonal therapy. Forander et al 
have  suggested  that  Tamoxifen  prevents  vaginal  atrophy and improves  sexual 
function [37].82.4% of our patients had received hormonal therapy.  Our study 
also showed that patients with hormonal therapy with Tamoxifen had significantly 
higher  sexual  function  when  compared  to  those  who  did  not  receive  Hence 
hormonal therapy could be a confounding factor. 
The  impact  of  BCT  and  MRM  on  QOL  has  shown  contradictory  results  in 
different  studies.  A  study  by  Janni  et  al  [48]  showed  no  difference  was  observed 
between  the  two  groups  in  the  QOL which  was  administered  46  months  following 
primary treatment. In contrast Cohen et al found that women who had BCT experienced 
significantly  greater  psychological  distress  and  marginally  worse  quality  of  life  40 
months after surgery. [49]
2. Impact of quality of life on ovarian function.
The  patients  with  ovarian  ablation  had  slightly  more  vaginal  dryness,  vaginal 
discharge and dysparuenia than the ovary preserved group which was statistically not 
significant.
Bonnie et al in her review on breast cancer in young women- Effect on ovarian 
function, fertility and birth defects has described hot flashes, decreased libido, changes 
in  sleep  pattern,  irritability,  vaginal  discharge  and/or  dryness  and  dysparuenia  as 
common symptoms after ovarian ablation [50]
Though the patients with ovarian ablation had more sexual symptoms their sexual 
function  and  enjoyment  was  significantly  better  when compared to  ovary  preserved 
group.  This  could be explained by the hormone therapy which all  the  patients  with 
ovarian ablation received. 
The  sexual  function  and  enjoyment  was  lower  in  the  ovary  preserved  group. 
Patients in the ovary preserved group had more patients with breast conservation with 
arm symptoms and hence affecting the overall quality of life including sexual function.
In our study chemotherapy induced amenorrhea was seen in 17.6% of the patients. 
11.6% of the patients had temporary amenorrhea and 6% had permanent amenorrhea.
In the review by Bonnie et al, of the 128 patients, 59% continued to menstruate, 
32% experienced temporary amenorrhea and 9% experienced permanent amenorrhea. 
[50]
The incidence  of  chemotherapy  amenorrhea  appears  to  be  slightly  less  in  our 
study.
3 patients had successful pregnancy following completion of surgery. The data on 
this subject is limited.
Survival duration and quality of life
The patients were divided into two groups .One group was with patients within 5 
years after diagnosis and the other more than 5 years after diagnosis. Our study showed 
that the global quality of life and other functional scores were similar in both the groups. 
It is difficult to interpret because the initial scores at diagnosis are not available.
Limitations of the study
1. The initial quality of life scores in these long term survivors are not available 
for comparison
2. There are wide varieties of definitions of concepts and of applied assessment 
instruments for measuring the quality of life making it difficult for studies to 
be compared. Hence more studies in this subset of patients in the near future 
may throw some light. 
CONCLUSION
 The effect of breast cancer on the occupation and marital status appears to be 
minimal.
 The overall quality of life with the exception of sexual function appears to be 
good. 
 The quality  of life and sexual  function was marginally  worse in the breast 
conserved group when compared to mastectomy. 
 Adjuvant  hormonal  therapy  with  Tamoxifen  significantly  improved  sexual 
symptoms.
 Preparing younger women for the impact of breast cancer and helping them 
deal with problems may improve their quality of life.
 Younger  breast  cancer  survivors  may  be  in  need  of  interventions  that 
specifically target these issues like non systemic products to alleviate vaginal 
dryness and also programs to help women deal with body image concerns.
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PROFORMA
Clinical Index No. :                                               Out Patient No. :
Age at diagnosis :                                               Name & Address :
Current Age                      :                                                 
Sex :                                                Phone No                  :
Occupation  
                         Past          :
                         Present     :
Education :
Stage                                 :
Date of admission :
Treatment
                       Surgery      : Yes / No               IF Yes                   : MRM / BCS
                Chemotherapy  : Yes / No               IF Yes                   : CMF / FAC
                Radiotherapy    : Yes / No
            Hormone therapy  : Yes / No           Receptor status         : ER / PR / UNKNOWN
                                BSO   : Yes / No
             Radiocastration     : Yes / No              
History of cancer in the family : Yes / No
Menstrual History                        
              Menstruation       : Yes / No
              Cycles    
- No . of days :
- Regular / Irregular 
- Menorrhagia / Oligomenorhea
Contraception                    : Yes / No                IF Yes  - Type     :
 
Premature Menopause leading to loss of Fertility                         : Yes / No
Chemotherapy induced Amenorrhea                                              : Yes / No
Marital status at Diagnosis : Single / Married / Divorced / Widowed
Current Marital status                  :  Single / Married / Divorced / Widowed
No. of children :      Supported by   :
Childbirth after Treatment            : Yes / No       IF Yes, How Many :
Any Abortions                              : Yes / No       IF Yes, How Many :
Do you have fear for recurrence.y/n
Do you have fear of functional disability y/n
Are you neglected by your partner y/n
Does your partner over protect you? y/n.
Do you have hot flashes? y/n
Do you have vaginal dryness? y/n
Do you have vaginal discharge ? y/n
Do you have pain during sexual intercourse ? y/n
Date of Interview :
Interviewer’s Signature :                                                        Time taken:
